The Consolidated Appropriations Act of 2023 included a new, one-time requirement for any Drug Enforcement Administration (DEA)-registered (non-veterinarian) practitioner to complete eight hours of training that addresses “the treatment and management of patients with opioid or other substance use disorders.” A DEA notice provides details about how the requirement can be satisfied and how affected practitioners will demonstrate compliance with the training requirement beginning June 27.
Practitioners will be required to check a box on their online DEA registration form affirming that they completed the new training requirement. The deadline for satisfying this new training requirement is the date of a practitioner’s next scheduled DEA registration submission — regardless of whether it is an initial registration or a renewal registration — on or after June 27.
A variety of continuing medical education (CME) and non-CME activities could satisfy the requirement, depending on individual circumstances. The American Medical Association (AMA) has developed a variety of training modules (total of 36.5 hours) — many of which are free — that can be used to meet the federal requirement.
For more information, contact Gloria Romanelli, American College of Radiology® Senior Director, Legislative and Regulatory Relations, Legal Counsel, Quality and Safety.
Make America Healthy Again
President Trump released an Executive Order (EO) establishing the "Make America Healthy Again (MAHA) Commission,” Feb. 13 to be led by the new Department of Health and Human Services Secretary Robert F. Kennedy Jr.
Read moreScope of Practice Bills Introduced At State Legislative Level
The American College of Radiology® (ACR®) is tracking more than 58 scope of practice bills across 22 states with more expected to be considered.
Read moreACR Others Challenge MAC Position on Minimally Invasive Arthrodesis of the Sacroiliac Joint
The American College of Radiology® (ACR®) and other medical specialty societies that use or perform interventional pain and spine procedures told three of the seven Medicare Administrative Contractors (MACs) that implementation of a new policy as written could limit access to a safe, effective and durable treatment option, potentially exacerbating healthcare disparities among Medicare patients.
Read more